Back
EPAM Systems Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
19
EPAM
EPAM Systems
Last Price:
$174.87
Seasonality Move:
10.6%
Sell
30
SRPT
Sarepta Therapeutics
Last Price:
$17.10
Seasonality Move:
17.08%
Sell
19
EPAM Systems (EPAM)
is a Sell
Is EPAM Systems a Buy, Sell or Hold?
-
The current EPAM Systems [EPAM] share price is $174.93. The Score for EPAM is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
EPAM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $17.11. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EPAM Stock Price Chart
What is EPAM Systems's stock price today?
-
The EPAM Systems share price today is $174.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EPAM is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $17.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
EPAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 53.17 | Buy |
| Chaikin Money Flow: | 447422 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (169.53 - 177.81) | Buy |
| Bollinger Bands (100): | (151.96 - 218.62) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.1 | Sell |
| Relative Strength Index (14 RSI): | 18.51 | Sell |
| Chaikin Money Flow: | -2892309 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.2 - 41) | Sell |
| Bollinger Bands (100): | (34.03 - 95.19) | Sell |
EPAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 169.93 | Buy |
| 20-day SMA: | 173.02 | Buy |
| 50-day SMA: | 170.12 | Buy |
| 200-day SMA: | 203.42 | Sell |
| 8-day EMA: | 172.23 | Buy |
| 20-day EMA: | 172.46 | Buy |
| 50-day EMA: | 160.57 | Buy |
| 200-day EMA: | 84.17 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.01 | Sell |
| 20-day SMA: | 29.95 | Sell |
| 50-day SMA: | 40.46 | Sell |
| 200-day SMA: | 93.66 | Sell |
| 8-day EMA: | 20.36 | Sell |
| 20-day EMA: | 27.35 | Sell |
| 50-day EMA: | 40.52 | Sell |
| 200-day EMA: | 81.56 | Sell |
EPAM Systems Earnings Growth & EPAM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.04 per share, and an increase next year of $1.22 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.86 per share, a decrease this year of $5.90 per share, and an increase next year of $5.54 per share.
EPAM Systems Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||